Dr. Handza is a Board Certified Ophthalmologist who is fellowship trained in the treatment of all medical and surgical retinal disease and laser surgery. This includes diabetic retinopathy, macular degeneration, retinal tears and detachments. Dr. Handza graduated from the University of Pittsburgh with a Bachelor of Science in Neuroscience. He received his medical degree with honors from the Philadelphia College of Osteopathic Medicine and completed his ophthalmology residency at Kettering Medical Center/Grandview Hospital.

Gulf Coast Eye Care

Independent Contractor

1515 9th Avenue North

St. Petersburg, FL 33705

map/directions

Tel: (727) 895-2020

Fax: (727) 823-8796

Jason M. Handza, D.O.

Gulf Coast Retina Specialists

3001 Eastland Blvd, Suite 1

Clearwater, FL 33761

map/directions

Tel: (727) 862-3090

Fax: (727) 862-3023


Gulf Coast Retina Specialists

Primary contact site

2055 Little Road

Trinity, FL 34655



Tel: (727) 862-3090

Fax: (727) 862-3023

Jason M. Handza, D.O.

Board Certified Ophthalmologist

Fellowship Trained Vitreoretinal Surgeon

Gulf Coast Retina Specialists 

Eye Associates of Pinellas

​Independent Contractor

9375 66th Street North

Pinellas Park, FL 33782

map/directions

Tel: (727) 541-4469

​Fax: (727) 546-9661

    He then completed a post graduate fellowship in vitreoretinal surgery at the nationally respected University of South Florida Eye Institute. He was twice awarded the prestigious Patrick Murray Award given by the American Osteopathic College of Ophthalmology to a physician demonstrating “professional proficiency, unusual merit and skills in the practice of ophthalmology. He also received the coveted Galen S. Young, Sr. Award from the P.C.O.M. Department of Surgery for his exceptional surgical ability. He has been delivering specialty eye care in Florida since 2004. 


    Dr. Handza has trained with many highly respected physicians considered to be experts in the field of ophthalmology and vitreoretinal surgery. As a Co-Investigator, he has been on the forefront of research aimed at the treatment of macular degeneration and diabetic retinopathy. His research was focused on the study of Lucentis for macular degeneration, including two different Phase III trials of rhuFab V2 [Ranibizumab]; (ANCHOR) and (MARINA) by Genentech, one Phase I/II trial of rhuFab V2 [Ranibizumab], and the Phase III trial of Protein Kinase C B Inhibitor - Diabetic Retinopathy Study 2 (PKC-DRS2) by Eli Lilly. He regularly lectures at and attends conferences and educational programs on the most recent advances in the field of ophthalmology and vitreoretinal surgery. He is an active member of the American Society of Retina Specialists, the American Academy of Ophthalmology and the American Osteopathic Academy of Ophthalmology. He has been appointed to the medical staff at Largo Medical Center.

Office Locations